Literature DB >> 1377587

In vivo measurement of hypothalamic serotonin release by intracerebral microdialysis: significant enhancement by immobilization stress in rats.

N Shimizu1, S Take, T Hori, Y Oomura.   

Abstract

Intracerebral microdialysis was used to measure extracellular serotonin and its metabolite 5-hydroxyindoleacetic acid (5-HIAA) in the hypothalamus of unanesthetized rats. Increase in the concentration of K+ in the perfusing Ringer solution (70 mM) produced a sharp increase in serotonin release, which was significantly attenuated by omitting Ca2+ from the perfusion medium. Intraperitoneal injection of 5-hydroxytryptophan, a precursor of serotonin, or local perfusion of pargyline, a monoamine oxidase inhibitor, elevated the hypothalamic serotonin. Releasers or uptake inhibitors of serotonin, such as fenfluramine, cocaine, mazindol, or imipramine, when added to the perfusion medium, significantly increased serotonin level, whereas 5-HIAA was unaffected by these substances. Immobilization-stress caused an immediate increase in both the extracellular serotonin and 5-HIAA in the hypothalamus, suggesting that the hypothalamic serotonergic system is activated during immobilization stress. The present study indicates that the brain microdialysis is useful for analysis of local changes in serotonin concentration which directly reflect neuronal transmission.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1377587     DOI: 10.1016/0361-9230(92)90252-s

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  16 in total

1.  Autoradiographic characterization of [3H]-5-HT-moduline binding sites in rodent brain and their relationship to 5-HT1B receptors.

Authors:  I Cloëz-Tayarani; A Cardona; J C Rousselle; O Massot; L Edelman; G Fillion
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Organic cation transporter inhibition increases medial hypothalamic serotonin under basal conditions and during mild restraint.

Authors:  Na Feng; Christopher A Lowry; Jodi L Lukkes; Miles Orchinik; Gina L Forster; Kenneth J Renner
Journal:  Brain Res       Date:  2010-02-19       Impact factor: 3.252

3.  Peripheral ChE inhibition modulates brain monoamines levels and c-fos oncogene in mice subjected to a stress situation.

Authors:  L Taysse; D Christin; S Delamanche; B Bellier; P Breton
Journal:  Neurochem Res       Date:  2005-03       Impact factor: 3.996

4.  Progesterone reduces the inhibitory effect of a serotonin 1B receptor agonist on lordosis behavior.

Authors:  Lynda Uphouse; Jutatip Guptarak; Cindy Hiegel
Journal:  Pharmacol Biochem Behav       Date:  2010-09-09       Impact factor: 3.533

5.  Effect of SB 200646A, a 5-HT2C/5-HT2B receptor antagonist, in two conflict models of anxiety.

Authors:  G A Kennett; F Bailey; D C Piper; T P Blackburn
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

6.  Influence of repeated cocaine exposure on the endocrine and behavioral responses to stress in rats.

Authors:  A D Levy; P A Rittenhouse; Q Li; J Yracheta; K Kunimoto; L D Van de Kar
Journal:  Psychopharmacology (Berl)       Date:  1994-01       Impact factor: 4.530

7.  Progesterone reduces the effect of the serotonin 1B/1D receptor antagonist, GR 127935, on lordosis behavior.

Authors:  Lynda Uphouse; Cindy Hiegel; Jutatip Guptarak; Navin Maswood
Journal:  Horm Behav       Date:  2008-10-08       Impact factor: 3.587

Review 8.  Role of interleukin-1 in stress responses. A putative neurotransmitter.

Authors:  F Shintani; T Nakaki; S Kanba; R Kato; M Asai
Journal:  Mol Neurobiol       Date:  1995-02       Impact factor: 5.590

9.  Changes in monoamine levels in mouse brain elicited by forced-swimming stress, and the protective effect of a new monoamine oxidase inhibitor, RS-8359.

Authors:  H Miura; M Naoi; D Nakahara; T Ohta; T Nagatsu
Journal:  J Neural Transm Gen Sect       Date:  1993

10.  Long-lasting effects of chronic stress on DOI-induced hyperthermia in male rats.

Authors:  Leslie Matuszewich; Bryan K Yamamoto
Journal:  Psychopharmacology (Berl)       Date:  2003-05-27       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.